Managed Account Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$58.2M Sell
796,115
-707,231
-47% -$51.1M 0.05% 374
2015
Q1
$98.3M Sell
1,503,346
-1,109,996
-42% -$73.8M 0.09% 262
2014
Q4
$170M Buy
2,613,342
+1,112,965
+74% +$71.7M 0.17% 152
2014
Q3
$90.2M Buy
1,500,377
+394,564
+36% +$25.8M 0.1% 237
2014
Q2
$76.6M Buy
1,105,813
+113,571
+11% +$7.36M 0.09% 262
2014
Q1
$64.9M Sell
992,242
-271,913
-22% -$17.7M 0.08% 280
2013
Q4
$78.3M Sell
1,264,155
-453,326
-26% -$26.3M 0.11% 232
2013
Q3
$92.1M Sell
1,717,481
-447,689
-21% -$23.1M 0.14% 183
2013
Q2
$98.8M Buy
+2,165,170
New +$93.8M 0.15% 159

Other funds holding STJ

Managed Account Advisors's STJ Position: Q2 2015 in Review

Managed Account Advisors reduced its St Jude Medical (STJ) stake by 47% in Q2 2015, selling an estimated $51.1M and leaving 796,115 shares worth $58.2M. The position accounts for 0.05% of the portfolio, ranked #374.

Managed Account Advisors first reported a position in STJ in Q2 2013 and has held it in 9 quarters since. The position peaked at $170M in Q4 2014. 608 funds tracked by Wall St. Rank hold STJ as of Q2 2015.

  • Managed Account Advisors held 796,115 shares of St Jude Medical worth $58.2M as of Q2 2015.
  • Managed Account Advisors sold 707,231 St Jude Medical shares in Q2 2015, an estimated $51.1M.
  • St Jude Medical made up 0.05% of Managed Account Advisors's portfolio in Q2 2015, its #374 holding.
  • Managed Account Advisors first reported a position in St Jude Medical in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's St Jude Medical position peaked at $170M in Q4 2014.
  • 608 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.